select a format
NEWSLETTER BY CATEGORY
Recent Viewed Reports
Why Ken Reasearch?
The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements.... "Senior Associate, Booz Allen Hamilton"
This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"
I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"
While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"
We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"
Enzymotec Ltd-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.
Detailed information on Enzymotec Ltd required for business and competitor intelligence needs
A study of the major internal and external factors affecting Enzymotec Ltd in the form of a SWOT analysis
An in-depth view of the business model of Enzymotec Ltd including a breakdown and examination of key business segments
Intelligence on Enzymotec Ltd's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Enzymotec Ltd, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
Gain understanding of Enzymotec Ltd and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess Enzymotec Ltd as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Enzymotec Ltd's business structure, strategy and prospects.
Enzymotec Ltd(Enzymotec) develops, manufactures and markets nutritional ingredients and medical foods in Israel. The company offers wide range of lipid based products, such as lipid based medicines, lipid compositions for infant formula and bioactive ingredients for the pharmaceutical and nutritional industries. Enzymotec partners with pharmaceutical companies such as AAK, Elder, DKSH, Teva Pharmaceutical, PFM medical, Daiichi Sankyo, Inc and Sechang Int'l Corp. Its operations are spread in several countries across North America, Europe, Australia, Oceania, the Middle East and Asia. The company also operates research and development, and production facilities in Northern Israel. Enzymotec is headquartered in Migdal Ha'Emeq, Israel.
Enzymotec Ltd: Company Overview
Enzymotec Ltd: Overview and Key Facts
Enzymotec Ltd: Overview
Enzymotec Ltd: Key Facts
Enzymotec Ltd: Key Employees
Enzymotec Ltd: Key Employee Biographies
Enzymotec Ltd: Major Products and Services
Enzymotec Ltd: Company History
Enzymotec Ltd: Management Statement
Enzymotec Ltd: Locations and Subsidiaries
Enzymotec Ltd: Key Competitors
Enzymotec Ltd: Company Analysis
Enzymotec Ltd: Business Description
Enzymotec Ltd: SWOT Analysis
Enzymotec Ltd: SWOT Overview
Enzymotec Ltd: Strengths
Enzymotec Ltd: Weaknesses
Enzymotec Ltd: Opportunities
Enzymotec Ltd: Threats
Enzymotec Ltd: Corporate Financial Deals Activity
Enzymotec Ltd: Financial Deals Overview
Enzymotec Ltd: Targets and Partners
Enzymotec Ltd: Top Deals 2013-2017YTD*
Enzymotec Ltd: Capital Raising
Enzymotec Ltd: Partnership
Enzymotec Ltd: Recent Developments
Enzymotec Ltd: News and Events Summary
Enzymotec Ltd: Corporate Governance
Enzymotec Ltd: Financial Performance
Figure 1: Enzymotec Ltd: Deal Activity by Deal Type-Volume (2013-YTD*2017)
Figure 2: Enzymotec Ltd: Capital Raising Volume and Value Trend (2013-YTD*2017)
Figure 3: Enzymotec Ltd: Capital Raising by Deal Type (2013-YTD*2017)
Figure 4: Enzymotec Ltd: Partnership Volume and Value Trend (2013-YTD*2017)
Figure 5: Enzymotec Ltd: Partnership Trend by Deal Type (2013-YTD*2017)
Table 1: Enzymotec Ltd: Key Facts
Table 2: Enzymotec Ltd: Key Employees
Table 4: Enzymotec Ltd: Key Competitors
Table 5: Enzymotec Ltd: Deal Activity by Deal Type-Volume (2013-YTD*2017)
Table 6: Enzymotec Ltd: Targets and Partners
Table 7: Enzymotec Ltd: Top Deals 2013-2017YTD*
Table 8: Enzymotec Ltd: Capital Raising Volume and Value Trend (2013-YTD*2017)
Table 9: Enzymotec Ltd: Capital Raising by Deal Type (2013-YTD*2017)
Table 10: Enzymotec Ltd: Partnership Volume and Value Trend (2013-YTD*2017)
Table 11: Enzymotec Ltd: Partnership Trend by Deal Type (2013-YTD*2017)
Table 12: Enzymotec Ltd: News and Events Summary
Table 13: Enzymotec Ltd: Corporate Governance
Table 14: Enzymotec Ltd: Financial Performance
Single User License:
Corporate User License: